Howard Berman

Insider Reports History

Location
Houston, TX
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Howard Berman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Howard Berman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 164,800 20 Jun 2025 Direct
Coya Therapeutics, Inc. Director Stock Option (right to buy) 150,602 09 Jan 2025 Direct

Insider Reports Filed by Howard Berman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVIR Atea Pharmaceuticals, Inc. 20 Jun 2025 1 $0 4 Director 24 Jun 2025, 18:05
AVIR Atea Pharmaceuticals, Inc. 20 Jun 2025 0 $0 3 Director 24 Jun 2025, 18:00
COYA Coya Therapeutics, Inc. 09 Jan 2025 1 $0 4 Director 13 Jan 2025, 08:00
COYA Coya Therapeutics, Inc. 03 Jun 2024 1 $0 4 Chief Executive Officer, Director 05 Jun 2024, 20:00
COYA Coya Therapeutics, Inc. 31 Jan 2024 1 $0 4 Chief Executive Officer, Director 02 Feb 2024, 20:00
COYA Coya Therapeutics, Inc. 27 Feb 2023 1 $0 4 Chief Executive Officer, Director 01 Mar 2023, 15:05
COYA Coya Therapeutics, Inc. 03 Jan 2023 0 $0 4/A Chief Executive Officer, Director, 10%+ Owner 17 Jan 2023, 19:01
COYA Coya Therapeutics, Inc. 28 Dec 2022 0 $0 3 Chief Executive Officer, Director, 10%+ Owner 28 Dec 2022, 19:37